(HealthDay)—Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer and neutropenia who ...
Jan 30, 2013
0
0
Data published online today in Blood, the Journal of the American Society of Hematology (ASH) describe the work of an ASH international clinical network collaborative focused on modernizing treatment protocols for patients ...
Jan 14, 2013
0
0
Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
Jan 11, 2013
0
0
A team of Spanish researchers say they have developed a therapeutic vaccine that can temporarily brake growth of the HIV virus in infected patients.
Jan 3, 2013
3
0
(HealthDay)—Ted Adamson's liver had been so ravaged by the hepatitis C virus that he was nearly at the point of needing a liver transplant. Yet he had no symptoms. None. He didn't even feel tired.
Dec 21, 2012
0
0
(HealthDay)—For patients with early rheumatoid arthritis (RA), smoking status does not impact treatment response to early combination therapy or initial methotrexate treatment with step-up therapy, according to a study ...
Dec 21, 2012
0
0
In the worldwide battle to curtail malaria, one of the most prevalent and deadly infectious diseases of the developing world, drug after drug has fallen by the wayside as the malaria parasite has become resistant to it. Only ...
Dec 20, 2012
1
0
For individuals with obstructive sleep apnea traveling to higher altitudes (which may exacerbate symptoms), use of a combination therapy resulted in improvement in symptoms including reduced insomnia and better control of ...
Dec 11, 2012
0
0
Combination therapies for AIDS are becoming increasingly effective, but they cannot protect against other sexually transmitted illnesses. It is unsafe for patients taking antiretroviral drugs to stop using condoms. This is ...
Nov 30, 2012
0
0
(HealthDay)—Combination treatment with fenofibrate and simvastatin (FENO-S) significantly reduces postprandial (PP) triglyceride (TG) levels compared with simvastatin alone in all subjects, regardless of fasting TG level, ...
Nov 1, 2012
0
0
